<DOC>
	<DOCNO>NCT00959465</DOCNO>
	<brief_summary>The purpose study obtain immunogenicity safety data different dose level investigational H1N1 pandemic influenza vaccine healthy adult 18 year age old .</brief_summary>
	<brief_title>A/H1N1 Immunogenicity Safety Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject 18 59 year old ( age stratum A ) 60 year age older ( age stratum B ) time screen Subject understanding study , agree provision , give write informed consent prior study entry Subject generally healthy , determine investigator 's clinical judgment collection medical history performance physical examination Subject physically mentally capable participate study willing adhere study procedure include completion element study diary If female childbearing potential , subject negative urine pregnancy test result within 24 hour prior schedule first vaccination agree employ adequate birth control measure duration study Subject participate another clinical study involve investigational drug , biological product device within 30 day prior study enrollment schedule participate another clinical study involve investigational drug , biological device course study Subject history exposure A/H1N1/California/07/2009 virus history vaccination A/H1N1/California/07/2009 antigen closely related influenza virus antigen Subject inherit acquire immune deficiency Subject currently recent history significant neurological , cardiovascular pulmonary ( include asthma ) , hepatic , metabolic , rheumatic , autoimmune , hematological renal disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>